Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps

BACKGROUND: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a type 2 inflammatory disease treated with sinus surgery when refractory to medical intervention. However, recurrence postsurgery is common. Dupilumab, a fully human monoclonal antibody, blocks the shared receptor for interleukin 4 (IL...

Descripción completa

Detalles Bibliográficos
Autores principales: Hopkins, Claire, Wagenmann, Martin, Bachert, Claus, Desrosiers, Martin, Han, Joseph K., Hellings, Peter W., Lee, Stella E., Msihid, Jérôme, Radwan, Amr, Rowe, Paul, Amin, Nikhil, Deniz, Yamo, Ortiz, Benjamin, Mannent, Leda P., Rout, Rajesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359289/
https://www.ncbi.nlm.nih.gov/pubmed/33611847
http://dx.doi.org/10.1002/alr.22780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359289/
https://www.ncbi.nlm.nih.gov/pubmed/33611847
http://dx.doi.org/10.1002/alr.22780

Ejemplares similares